Jorkasky Diane
SEC Form 4 insider trading activity
Jorkasky Diane has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 29, 2025.
On the most recent filing, Jorkasky Diane is listed as Director at Altimmune, Inc. Inside the rolling window, Jorkasky Diane reported 1 open-market purchase totaling $2K in ALT and no open-market sales.
Companies traded
Other insiders at ALT
Insider Buying
$2K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jorkasky Diane made?
Jorkasky Diane has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Jorkasky Diane trade?
Jorkasky Diane has filed SEC Form 4 disclosures for 1 company, including ALT.
When was Jorkasky Diane's most recent SEC Form 4 filing?
Jorkasky Diane's most recent SEC Form 4 filing on Tracefour is dated Dec 29, 2025.
What is Jorkasky Diane's total buy and sell value in the current window?
Inside the rolling retention window, Jorkasky Diane bought $2K and sold $0 based on SEC Form 4 filings.
What was Jorkasky Diane's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 527 ALT shares on 2025-12-29, worth $2K, per SEC Form 4 filings.